Meta-analysis of granisetron versus ondansetron: Efficacy and safety in the prevention of acute emesis induced by high dose cisplatin containing schedules;Metaanálisis de granisetrón frente a ondansetrón: Eficacia y seguridad en la prevención de la emesis aguda inducida por quimioterapia con dosis altas de cisplatino

Medicina Clinica

Volumn 115, Issue 12, 2000, Pages 446-450

  Mendarte, Luis ^a   Aguas Compaired, Margarita ^b   Martínez Bernabé, Eva M ^b   Òdena Estradé, Eugènia ^d   Rodríguez Palomar, Gemma ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^c Corporacio Sanit del Parc Tauli ^*  (Spain)

^d NONE

Author keywords

Antiemetics; Cisplatin; Efficacy; Granisetron; Meta analysis; Ondansetron; Safety

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GRANISETRON; METHOTREXATE; MITOMYCIN C; NAVELBINE; ONDANSETRON;

ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VOMITING;

EID: 0343371331     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71588-0     Document Type: Article

References (29)

1. Miner WD, Sanger GJ. Inhibition of cisplatin induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 1986; 88: 497-499.
2. Mantovani G, Macció A, Bianchi A, Curreli L, Ghiani M, Proto E. Comparison of granisetron vs ondansetron vs tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a ramdcmized controlled trial. Cancer 1996; 77: 941-948.
3. Navari R, Gandara D, Hasketh P, Hall S, Maillard J, Ritter H et al. The granisetron study group. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. J Clin Oncol 1995; 13: 1242-1248.
4. Hesketh P, Navari R, Grate T, Gralla R, Hainsworth J, Kris M et al. Double blind, ramdomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of aute cisplatin-inducec emesis in patients with cancer. J Clin Oncol 1996; 14: 2242-2249.
5. Pérez EA. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis. J Clin Oncol 1995; 13: 1036-1043.
6. 3 receptor antagonists: differences and similarities. Eur J Cancer 1997; 33: 1364-1370.
7. Manual de la Colaboracián Cochrane (versión española de The Collaboration Handbook) [actualización de septiembre 1997]. Sabadell: Centro Cochrane Español, 1998.
8. Egger M, Davey Smith G, Phillips AN. Metaanalysis. Principles and procedures. Br Med J 1997; 315: 1533-1537.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
10. Ritter H, Hall S, Mailliard J, Navari RM, Friedman C. A comparative clinical trial of granisetron and ondansetron i the prophylaxis of cisplatin-induced emesis. Proc Annu Meet Am Soc Clin Oncol 1995; 14(A): 1739.
11. Roila F, De Angelis V, Cognetti F, Ricci S, Contu A, Nuzzo A et al. Ondansetron vs granisetron both combined with dexamethasone in the prevention of cisplatin-induced emesis. Proc Annu Meet Am Soc Clin Oncol 1995; 14(A): 1721.
12. Martoni A, Angelelli B, Guaraldi M, Strocchi E, Pannuti F. Granisetron (GRA) vs ondansetron (OND) in the prevention of cisplatin-induced emesis: an open randomized cross-over study. Proc Annu Meet Am Soc Clin Oncol 1994; 13 (A): 1481.
13. Mantovani G, Macciò A, Bianchi A, Gebbia V. Comparison of the effectiveness of three 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by highly emetogenic chemotherapy (high-dose cisplatin) for the treatment of primary head and neck cancer. Proc Annu Meet Am Soc Clin Oncol 1994; 13 (A): 1468.
14. Cho JY, Park JO, Rha SY, Yoo NC, Kim JH, Roh JK et al. A comparative study of granisetron IV versus ondansetron IV/oral in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy. Ann Oncol 1996; 7 (Supl 5): 686P.
15. Stewart L, Grawford SM. A double blind randomised trial of granisetron + dexamethasone (Dex) vs ondansetron + Dex in the treatment of cisplatin associated nausea and vomiting. Br J Cancer 1996; 73 (Supl XXVI): 51.
16. Robová H, Rob L, Bauer J, Citterbart K. Antiemetická lécba blokátory 5-HT3, srovnáni ondansetron (zofran), granisetron (kytril). Klinicka Ontologie 1996; 9: 98-102.
17. Gebbia V, Cannata G, Testa A, Curto G, Valenza R, Cipolla C et al. Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea aid vomiting. Cancer 1994; 74; 1945-1952.
18. Ruff P, Paska W, Goedhals L, Pouillart A, Rivière A, Vorobiof D et al. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. Oncology 1994; 51: 113-118.
19. Italian Group for Antiemetic Research. Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Ann Oncol 1995; 6: 805-810.
20. Martoni A, Angelelli B, Guaraldi M, Strocchi E, Pannuti F. An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens. Eur J Cancer 1996; 32A: 82-85.
21. Leonardi V, Iannitto E, Meli M, Malmeri S. Ondansetron (OND) vs granisetron (GRA) in the control of chemotherapy induced acute emesis: a multicentric randomized trial. Oncology Reports 1996; 3: 919-923.
22. Park JO, Rha SY, Yoo NC, Kim JH, Roh JK et al. A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy. Am J Clin Oncol 1997; 20: 569-572.
23. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9: 675-678.
24. Smith DB, Newlands ES, Rustin GJS, Begent RHJ, Howells N, McQuade B et al. Comparison of ondasetron and ondasetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991; 338: 487-490
25. Latreille J, Stewart D, Laberge F, Hoskins P, Rusthoven J, McMurtrie E et al. Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy. Support Care Cancer 1995; 3: 307-312.
26. Fleiss JL, Grass JA. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991; 44: 127-139.
27. 3, receptor antagonists: a retrospective comparison of ondansetron and granisetron. Anticancer Drugs 1995; 6: 243-249.
28. 3 reeptor antagonists in antineoplastic therapy-induced emesis. Drug Saf 1998; 18: 43-56.
29. Lau J, Ioannidis JPA, Schmid CH. Quantitative synthesis in systematic reviews. Ann Internal Med 1997; 127: 820-826.